Healthcare
1056 companies in this sector
Insider Buys (30d)
50
$10.00B
Insider Sells (30d)
313
$1.52B
Monthly Insider Volume
Industries
Biotechnology600 companies
Medical - Devices131 companies
Drug Manufacturers - Specialty & Generic64 companies
Medical - Instruments & Supplies50 companies
Medical - Diagnostics & Research49 companies
Medical - Care Facilities47 companies
Medical - Healthcare Information Services41 companies
Medical - Pharmaceuticals21 companies
Drug Manufacturers - General20 companies
Medical - Healthcare Plans12 companies
Medical - Specialties10 companies
Medical - Distribution8 companies
Medical - Equipment & Services3 companies
Top Companies by Market Cap
Recent Insider Trades
| Date | Ticker | Company | Insider | Role | Type | Shares | Avg Price | Value |
|---|---|---|---|---|---|---|---|---|
| Oct 30, 2026 | OTLC | ONCOTELIC THERAPEUTCS INC | Trieu Vuong | director, 10 percent owner, officer: CHAIRMAN AND CEO | Buy | 1,356,990 | $0.02 | $23.5K |
| Oct 30, 2026 | CSTL | Castle Biosciences, Inc. | Juvenal Tobin W | officer: Chief Commercial Officer | Sell | 6,578 | $36.42 | $239.6K |
| Oct 30, 2026 | RLAY | Relay Therapeutics, Inc. | Bergstrom Donald A | officer: President, R&D | Sell | 2,252 | $18.62 | $41.9K |
| Oct 30, 2026 | MAZE | Maze Therapeutics, Inc. | Dandekar Atul | officer: CSBO | Sell | 7,500 | $32.07 | $240.5K |
| Oct 30, 2026 | RLAY | Relay Therapeutics, Inc. | Catinazzo Thomas | officer: Chief Financial Officer | Sell | 1,469 | $18.62 | $27.4K |
| Oct 30, 2026 | UTHR | United Therapeutics Corporation | ROTHBLATT MARTINE A | director, officer: Chairperson & CEO | Sell | 9,500 | $594.78 | $5.65M |
| Oct 30, 2026 | IMVT | Immunovant, Inc. | Girao Tiago | officer: Chief Financial Officer | Sell | 6,606 | $28.50 | $188.3K |
| Oct 30, 2026 | ANIP | ANI Pharmaceuticals, Inc. | CAREY STEPHEN P. | officer: SVP & CFO | Sell | 2,850 | $72.87 | $207.7K |
| Oct 30, 2026 | TMO | Thermo Fisher Scientific Inc. | Britt Lisa P. | officer: Sr. VP and Chief HR Officer | Sell | 2,831 | $706.45 | $2.00M |
| Oct 30, 2026 | BLLN | BillionToOne, Inc. | Atay Oguzhan | director, officer: Chairman and CEO | Sell | 11,000 | $118.00 | $1.30M |
| Oct 30, 2026 | RLAY | Relay Therapeutics, Inc. | Rahmer Peter | officer: See remarks | Sell | 753 | $18.62 | $14.0K |
| Oct 30, 2026 | SNDX | Syndax Pharmaceuticals, Inc. | Podlesak Dennis | director | Sell | 8,000 | $14.21 | $113.7K |
| Oct 30, 2026 | PACS | PACS Group, Inc. | Hancock Mark | director, 10 percent owner: | Sell | 13,304 | $50.08 | $666.2K |
| Oct 30, 2026 | PACS | PACS Group, Inc. | Lewis Michelle Renee | officer: Chief Accounting Officer | Sell | 11,828 | $50.11 | $592.6K |
| Oct 30, 2026 | PACS | PACS Group, Inc. | Murray Jason Hulse | director, 10 percent owner, officer: Co-Founder, CEO & Chairman | Sell | 8,803 | $50.09 | $440.9K |
| Oct 30, 2026 | RAPP | Rapport Therapeutics, Inc. Common Stock | HEALY JAMES | director | Buy | 969,480 | $21.00 | $20.36M |
| Oct 30, 2026 | ANGO | AngioDynamics, Inc. | Trowbridge Stephen A | officer: EVP and CFO | Sell | 25,335 | $12.26 | $310.7K |
| Oct 30, 2026 | ACAD | Acadia Pharmaceuticals Inc. | Schneyer Mark C. | officer: EVP, CHIEF FINANCIAL OFFICER | Sell | 3,321 | $20.88 | $69.3K |
| Oct 30, 2026 | NTRA | Natera, Inc. | Brophy Michael Burkes | officer: CHIEF FINANCIAL OFFICER | Sell | 3,084 | $425.90 | $1.31M |
| Oct 29, 2026 | BBNX | Beta Bionics, Inc. | Mensinger Mike | officer: Chief Product Officer | Sell | 2,650 | $22.00 | $58.3K |
| Oct 29, 2026 | TEM | Tempus AI, Inc. | LEFKOFSKY ERIC P | director, 10 percent owner, officer: CEO and Chairman | Sell | 250,000 | $70.36 | $17.59M |
| Oct 29, 2026 | TNDM | Tandem Diabetes Care, Inc. | TWOMEY CHRISTOPHER J | director | Sell | 1,700 | $19.15 | $32.6K |
| Oct 29, 2026 | NTRA | Natera, Inc. | Moshkevich Solomon | officer: PRESIDENT, CLINICALDIAGNOSTICS | Sell | 2,172 | $416.88 | $905.5K |
| Oct 29, 2026 | DHR | Danaher Corporation | Bouda Christopher | officer: VP, Chief Accounting Officer | Sell | 7,598 | $234.56 | $1.78M |
| Oct 29, 2026 | UTHR | United Therapeutics Corporation | ROTHBLATT MARTINE A | director, officer: Chairperson & CEO | Sell | 9,500 | $585.49 | $5.56M |
| Oct 29, 2026 | BOLD | Boundless Bio, Inc. | TANG KEVIN | 10 percent owner | Buy | 10,707 | $2.40 | $25.7K |
| Oct 29, 2026 | ACTU | Actuate Therapeutics Inc | SCHMITT DANIEL M | director, officer: President, CEO and Director | Buy | 211,266 | $0.39 | $81.7K |
| Oct 29, 2026 | NTRA | Natera, Inc. | Sheena Jonathan | director, other: CO-FOUNDER | Sell | 478 | $413.96 | $197.9K |
| Oct 29, 2026 | HIMS | Hims & Hers Health, Inc. | Boughton Soleil | officer: Chief Legal Officer | Sell | 3,462 | $27.60 | $95.6K |
| Oct 29, 2026 | NTRA | Natera, Inc. | RABINOWITZ DANIEL | officer: SEC. AND CHIEF LEGAL OFFICER | Sell | 1,852 | $416.63 | $771.6K |
| Oct 29, 2026 | DHR | Danaher Corporation | McGrew Matthew | officer: Executive Vice President | Sell | 29,754 | $235.74 | $7.01M |
| Oct 29, 2026 | UTMD | Utah Medical Products, Inc. | CORNWELL KEVIN L | director, officer: Chairman, CEO | Buy | 1,000 | $66.75 | $66.8K |
| Oct 29, 2026 | NTRA | Natera, Inc. | Chapman Steven Leonard | director, officer: CEO AND PRESIDENT | Sell | 5,694 | $418.25 | $2.38M |
| Oct 29, 2026 | NTRA | Natera, Inc. | Brophy Michael Burkes | officer: CHIEF FINANCIAL OFFICER | Sell | 1,979 | $418.31 | $827.8K |
| Oct 29, 2026 | ADPT | Adaptive Biotechnologies Corporation | RUBINSTEIN JULIE | officer: President and COO | Sell | 35,643 | $28.00 | $998.1K |
| Oct 29, 2026 | NTRA | Natera, Inc. | Rabinowitz Matthew | director, officer: EXECUTIVE CHAIRMAN | Sell | 1,718 | $406.00 | $697.5K |
| Oct 29, 2026 | DVA | DaVita Inc. | BERKSHIRE HATHAWAY INC | 10 percent owner | Sell | 382,563 | $180.43 | $69.03M |
| Oct 29, 2026 | NTRA | Natera, Inc. | Fesko John | officer: PRESIDENT, CHIEF BUS. OFFICER | Sell | 1,679 | $416.88 | $699.9K |
| Oct 28, 2026 | LQDA | Liquidia Corporation | Boyle Dana | officer: Chief Accounting Officer | Sell | 1,581 | $43.19 | $68.3K |
| Oct 28, 2026 | VCYT | Veracyte, Inc. | EASTHAM KARIN | director | Sell | 14,850 | $50.00 | $742.6K |
| Oct 28, 2026 | UTHR | United Therapeutics Corporation | ROTHBLATT MARTINE A | director, officer: Chairperson & CEO | Sell | 8,083 | $588.24 | $4.75M |
| Oct 28, 2026 | RLYB | Rallybio Corporation | Lieber Jonathan I | officer: Chief Financial Officer | Sell | 599 | $16.04 | $9.6K |
| Oct 28, 2026 | ISRG | Intuitive Surgical, Inc. | Brosius Mark | officer: EVP & Chief Mfg and Supply Cha | Sell | 183 | $448.33 | $82.0K |
| Oct 28, 2026 | DGX | Quest Diagnostics Incorporated | PFEIFFER GARY M | director | Sell | 1,203 | $243.00 | $292.3K |
| Oct 28, 2026 | RVMD | Revolution Medicines, Inc. | Mancini Anthony | officer: See Remarks | Sell | 2,310 | $186.99 | $431.9K |
| Oct 28, 2026 | LONA | LeonaBio, Inc. | Portman David J. | 10 percent owner | Buy | 3,149,470 | $3149.47 | $9.92B |
| Oct 28, 2026 | AGIO | Agios Pharmaceuticals, Inc. | Gheuens Sarah | officer: Chief Medical Officer | Sell | 7,866 | $37.69 | $296.5K |
| Oct 28, 2026 | BBNX | Beta Bionics, Inc. | Hopman Mark | officer: Chief Commercial Officer | Sell | 821 | $20.00 | $16.4K |
| Oct 28, 2026 | CSTL | Castle Biosciences, Inc. | Juvenal Tobin W | officer: Chief Commercial Officer | Sell | 3,288 | $33.08 | $108.8K |
| Oct 28, 2026 | XBIT | XBiotech Inc. | SIMARD JOHN | director, 10 percent owner: | Buy | 368,524 | $1.93 | $711.3K |
Showing 1–50 of 363
1 / 8
...